Johns Hopkins HIV Guide
Atazanavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other ARVs.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 8, 2023
Citation
Auwaerter, Paul G, and Janessa M Smith. "Atazanavir." Johns Hopkins HIV Guide, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545014/all/Atazanavir.
Auwaerter PG, Smith JM. Atazanavir. Johns Hopkins HIV Guide. 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545014/all/Atazanavir. Accessed September 25, 2023.
Auwaerter, P. G., & Smith, J. M. (2023). Atazanavir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545014/all/Atazanavir
Auwaerter PG, Smith JM. Atazanavir [Internet]. In: Johns Hopkins HIV Guide. ; 2023. [cited 2023 September 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545014/all/Atazanavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Atazanavir
ID - 545014
A1 - Auwaerter,Paul,M.D.
AU - Smith,Janessa,Pharm.D., BCPS
Y1 - 2023/08/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545014/all/Atazanavir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
